ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

13 links0 made here, not in the record27 judgments3 judges (the rules as one: Rule based)0 record changes seen
GPT-6.1 Sol (High)Claude Opus 5.5Rule based
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT03178552A Study to Evaluate theEfficacy and Safety ofMultiple Targeted Therapiesas Treatments forParticipants With Non-SmallCell Lung Cancer (NSCLC)Hoffmann-La RochePhase 2/Phase 3 · active not rRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSCarcinoma, Non-Small-Cell L…The registry's MeSH filing›Oct 20 · GPT-6.1 Sol (High) · RightNov 14 · Rule based · Finest filed termAs of now · Rule based · Main conditionMain conditionDRUGSAlectinibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedAtezolizumabIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedPemetrexedIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedCisplatinIntervention entry›Nov 3 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorCarboplatinIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedGemcitabineIntervention entry›Nov 3 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorEntrectinibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedCobimetinibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedVemurafenibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedBevacizumabIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedDivarasibIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedDocetaxelIntervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Carcinoma, Non-Small-Cell Lung

From the registry record3 judgments on this link
Fit of the first condition term, from the registry to what was judged
RegistryCarcinoma, Non-Small-Cell Lung, as filedthe registry files the study under it
→judged
Kind of condition link
Main condition (R9)

All judgments on this study

WhenLinkJudgeDecisionState
Oct 20Carcinoma, Non-Small-Cell LungGPT-6.1 Sol (High)RightCurrent
Nov 3AlectinibClaude Opus 5.5TestedCurrent
Nov 3AtezolizumabClaude Opus 5.5TestedCurrent
Nov 3PemetrexedClaude Opus 5.5TestedCurrent
Nov 3CisplatinClaude Opus 5.5ComparatorCurrent
Nov 3CarboplatinClaude Opus 5.5TestedCurrent
Nov 3GemcitabineClaude Opus 5.5ComparatorCurrent
Nov 3EntrectinibClaude Opus 5.5TestedCurrent
Nov 3CobimetinibClaude Opus 5.5TestedCurrent
Nov 3VemurafenibClaude Opus 5.5TestedCurrent
Nov 3BevacizumabClaude Opus 5.5TestedCurrent
Nov 3DivarasibClaude Opus 5.5TestedCurrent
Nov 3DocetaxelClaude Opus 5.5BackgroundCurrent
Nov 14Carcinoma, Non-Small-Cell LungRule based · condition-kind ruleFinest filed termCurrent
Nov 18AlectinibRule based · role ruleTestedAgrees
Nov 18AtezolizumabRule based · role ruleTestedAgrees
Nov 18PemetrexedRule based · role ruleTestedAgrees
Nov 18CisplatinRule based · role ruleComparatorAgrees
Nov 18CarboplatinRule based · role ruleTestedAgrees
Nov 18GemcitabineRule based · role ruleComparatorAgrees
Nov 18EntrectinibRule based · role ruleTestedAgrees
Nov 18CobimetinibRule based · role ruleTestedAgrees
Nov 18VemurafenibRule based · role ruleTestedAgrees
Nov 18BevacizumabRule based · role ruleTestedAgrees
Nov 18DivarasibRule based · role ruleTestedAgrees
Nov 18DocetaxelRule based · role ruleBackgroundAgrees
As of nowCarcinoma, Non-Small-Cell LungRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.

How a condition link is counted

For each condition a study is filed under: whether it is the study's own condition at the finest the study states it, a wider one, a general category, or filed by mistake; and whether it is the main condition, a setting the study names, or only how it was filed.

A decision on file for one study overrides it, with who made it and when.